These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4171834)

  • 1. Fibrinolytic activity and coronary-artery disease.
    Chakrabarti R; Hocking ED; Fearnley GR; Mann RD; Attwell TN; Jackson D
    Lancet; 1968 May; 1(7550):987-90. PubMed ID: 4171834
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypofibrinolysis in acute myocardial infarction (author's transl)].
    Bruhn HD; Jipp P; Okoye S; Oltmann A
    Med Klin; 1974 Nov; 69(47):1951-5. PubMed ID: 4444662
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolytic activity and coronary-artery disease.
    Lancet; 1968 May; 1(7550):1017-8. PubMed ID: 4171806
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolytic activity and postoperative deep-vein thrombosis.
    Fossard DP; Friend JR; Field ES; Corrigan TP; Kakkar VV; Flute PT
    Lancet; 1974 Jan; 1(7845):9-11. PubMed ID: 4129028
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological stimulation of fibrinolytic activity in the surgical patient.
    Brown IK; Haggart B; Murray GH; Downie RJ; Littler J; Robb PM; Santer GJ
    Lancet; 1971 Apr; 1(7703):774-6. PubMed ID: 4101274
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
    Chakrabarti R; Fearnley GR
    Lancet; 1972 Sep; 2(7777):556-9. PubMed ID: 4115736
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Fibrinolytic activity and postoperative deep-vein thrombosis.
    Chakrabarti R
    Lancet; 1974 May; 1(7862):868. PubMed ID: 4132820
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Nilsson IM; Isacson S
    J Clin Pathol; 1972 Jul; 25(7):638-9. PubMed ID: 5070268
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
    Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperfibrinogemia following activator therapy].
    Zawilska K; Jazienicki B
    Acta Haematol Pol; 1972; 3(1):53-8. PubMed ID: 4119480
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
    Fearnley GR; Chakrabarti R
    Lancet; 1966 Oct; 2(7467):757-61. PubMed ID: 4162320
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
    Fearnley GR; Chakrabarti R; Hocking ED
    Lancet; 1967 Nov; 2(7524):1008-11. PubMed ID: 4168522
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic study of fibrinogen and its split products in venous thrombosis.
    Sova J
    Acta Univ Carol Med Monogr; 1972; 52():173-9. PubMed ID: 4593289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic significance of the state of the blood coagulation system for the development of myocardial infarction and sudden death in patients with ischemic heart disease].
    Deriagina GP
    Kardiologiia; 1984 Oct; 24(10):69-73. PubMed ID: 6521187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic activity and coronary-artery disease.
    Naimi S; Proger S
    Lancet; 1968 Jun; 1(7554):1250-1. PubMed ID: 4172804
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigations on the changes of the blood coagulation-fibrinolysis system as a risk factor of coronary heart disease. II. Changes of platelets, fibrinogen and antiplasmins in a group of 2,000 middle aged men (40-60 years) periodically followed up for three years.
    Papilian M; Niţă I
    Med Interne; 1975; 13(4):271-82. PubMed ID: 128813
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of changes in the state of the blood coagulation and fibrinolysis system in the pathogenesis of myocardial infarct and atherosclerosis].
    Andreenko GV
    Kardiologiia; 1974 Nov; 14(11):139-46. PubMed ID: 4610256
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Isacson S; Nilsson IM
    Scand J Haematol; 1970; 7(5):404-8. PubMed ID: 5486783
    [No Abstract]   [Full Text] [Related]  

  • 20. Mode of action of phenformin plus ethyloestrenol on fibrinolysis.
    Fearnley GR; Chakrabarti R; Evans JF
    Lancet; 1971 Apr; 1(7702):723-5. PubMed ID: 4101428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.